MaRS Innovation joins the MaRS Discovery District in congratulating Dr. Ilse Treurnicht on receiving the prestigious 2012 Canada’s Most Powerful Women: Top 100™ Award.
The full release about Dr. Treurnicht's award is available on the MaRS Discovery District website.
The award, in the “Xstrata Nickel Trailblazers and Trendsetters” category, is Dr. Treurnicht’s third Top 100 recognition; she was previously honoured in 2009 and 2011.
Created by the Women’s Executive Network (WXN) in 2003, the Top 100 Awards celebrate the professional achievements of women across ...
Elizabeth Monier-Williams, MaRS Innovation's marketing and communications manager, is giving a Tedx talk at the TedxWaterlooWomen event in Waterloo, Ontario, on December 1.
Read the Kitchener-Waterloo Record's summary story and their curated highlights from the event's social chatter on Storify.
The event, hosted by the Centre for International Governance Innovation (CIGI), will include a live stream of talks from the second annual TedxWomen conference in Washington, D.C., along with talks by local speakers, including Monier-Williams, for the Waterloo audience.
Being named to the MIT Technology Review's 35 Inventors Under 35 list is a prestigious honour, but one of its best perks is the subsequent invitation to attend the Emerging Technologies conference (EmTech).
Joyce Poon and Hossein Rahnama, both researchers and inventors working with MaRS Innovation to license or spin-off technology projects, were named to the MIT Technology Review‘s prestigious 35 Inventors Under 35 list for 2012.
They attended the EmTech 2012 from October 24 to 26 where they each made a three-minute ...
Stem Cell Therapeutics Corp. (TSX VENTURE:SSS), a life sciences company developing stem cell-related technologies, today announced the signing of an agreement with University Health Network (UHN), through its commercialization agent MaRS Innovation (MI), both of Toronto.
The agreement provides Stem Cell Therapeutics ("SCT") with an option to an exclusive world-wide license to an innovative cancer stem cell program.
This agreement produced a license for a UHN technology on April 17, 2013.